Cargando…

Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)

INTRODUCTION: Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) affects 10–15% of the chronic dialysis population. We explored baseline characteristics and predictors of ESA hyporesponsiveness in a global randomized cardiovascular outcomes study comparing an investigational hypoxia-indu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Macdougall, Iain C., Meadowcroft, Amy M., Blackorby, Allison, Cizman, Borut, Cobitz, Alexander R., Godoy, Sergio, Jha, Vivekanand, Johansen, Kirsten L., McMahon, Gearoid, Obrador, Gregorio T., Wong, Muh Geot, Singh, Ajay K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Patient-Oriented, Translational Research: Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210075/ https://www.ncbi.nlm.nih.gov/pubmed/36739866 http://dx.doi.org/10.1159/000528696

Ejemplares similares

An Exploratory Study of Daprodustat in Erythropoietin-Hyporesponsive Subjects
por: Cizman, Borut, et al.
Publicado: (2018)

Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial
por: Singh, Ajay K., et al.
Publicado: (2022)

Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial
por: Singh, Ajay K, et al.
Publicado: (2021)

The ASCEND-ND trial: study design and participant characteristics
por: Perkovic, Vlado, et al.
Publicado: (2021)

Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis
por: Meadowcroft, Amy M, et al.
Publicado: (2018)

Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease
por: Holdstock, Louis, et al.
Publicado: (2018)

Effect of renal function and dialysis modality on daprodustat and predominant metabolite exposure
por: Caltabiano, Stephen, et al.
Publicado: (2019)

The drug interaction potential of daprodustat when coadministered with pioglitazone, rosuvastatin, or trimethoprim in healthy subjects
por: Caltabiano, Stephen, et al.
Publicado: (2018)

Clinical and Economic Outcomes of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Post-Bundling Era
por: Cizman, Borut, et al.
Publicado: (2020)

Efficacy and safety of daprodustat in Japanese peritoneal dialysis patients
por: Kanai, Hidetoshi, et al.
Publicado: (2021)

Pharmacokinetics of Daprodustat and Metabolites in Individuals with Normal and Impaired Hepatic Function
por: Mahar, Kelly M., et al.
Publicado: (2022)

Erythropoiesis-Stimulating Agent Hyporesponsiveness and Adverse Outcomes: Guilty as Charged?
por: Wish, Jay B.
Publicado: (2020)

Inflammation and Erythropoiesis-Stimulating Agent Hyporesponsiveness: A Critical Connection
por: Shah, Hitesh H., et al.
Publicado: (2020)

Daprodustat: First Approval
por: Dhillon, Sohita
Publicado: (2020)

Roxadustat treatment for erythropoiesis-stimulating agent-hyporesponsive anemia in maintenance hemodialysis patients
por: Song, Jie, et al.
Publicado: (2023)

Safety of daprodustat in patients with anemia of chronic kidney disease: A pooled analysis of phase 3 studies in Japan
por: Nangaku, Masaomi, et al.
Publicado: (2022)

Factors associated with erythropoiesis-stimulating agent hyporesponsiveness anemia in chronic kidney disease patients
por: Amnuay, Kamalas, et al.
Publicado: (2019)

Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study
por: Narita, Ichiei, et al.
Publicado: (2022)

Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes
por: Connelly, Philip W., et al.
Publicado: (2009)

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)
por: Deshmukh, Harshal A., et al.
Publicado: (2012)

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity
por: Rubinow, Katya B., et al.
Publicado: (2012)

Intake levels of dietary long-chain PUFAs modify the association between genetic variation in FADS and LDL-C
por: Hellstrand, S., et al.
Publicado: (2012)

Plasma apolipoprotein O level increased in the patients with acute coronary syndrome
por: Yu, Bi-lian, et al.
Publicado: (2012)

Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects
por: Ooi, Esther M. M., et al.
Publicado: (2012)

Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trial
por: Shearer, Gregory C., et al.
Publicado: (2012)

Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis
por: Gaspar, Paulo, et al.
Publicado: (2014)

New insights regarding tissue Se and Hg interactions on oxidative stress from plasma IsoP and IsoF measures in the Canadian Inuit population
por: Alkazemi, Dalal, et al.
Publicado: (2013)

Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia
por: Meikle, Peter J., et al.
Publicado: (2015)

Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies(1)
por: Tsiantoulas, Dimitrios, et al.
Publicado: (2015)

The implication of cigarette smoking and cessation on macrophage cholesterol efflux in coronary artery disease patients
por: Song, Wei, et al.
Publicado: (2015)

Genetic loci associated with circulating levels of very long-chain saturated fatty acids
por: Lemaitre, Rozenn N., et al.
Publicado: (2015)

Enhancement of lipid peroxidation and its amelioration by vitamin E in a subject with mutations in the SBP2 gene
por: Saito, Yoshiro, et al.
Publicado: (2015)

Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans
por: Bonde, Ylva, et al.
Publicado: (2014)

Adiposity significantly modifies genetic risk for dyslipidemia
por: Cole, Christopher B., et al.
Publicado: (2014)

Identification of a novel mutation in the PNLIP gene in two brothers with congenital pancreatic lipase deficiency
por: Behar, Doron M., et al.
Publicado: (2014)

Differential effects of EPA versus DHA on postprandial vascular function and the plasma oxylipin profile in men
por: McManus, Seán, et al.
Publicado: (2016)

The relationship between non-HDL cholesterol and macrophage phenotypes in human adipose tissue
por: Poledne, Rudolf, et al.
Publicado: (2016)

Association of peripheral differential leukocyte counts with dyslipidemia risk in Chinese patients with hypertension: insight from the China Stroke Primary Prevention Trial
por: Liu, Yanhong, et al.
Publicado: (2017)

Defective cholesterol metabolism in amyotrophic lateral sclerosis
por: Abdel-Khalik, Jonas, et al.
Publicado: (2017)

Normal human adipose tissue functions and differentiation in patients with biallelic LPIN1 inactivating mutations
por: Pelosi, Michele, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gd2rn14k2cjh0biebi681cv2pp